Great West Life Assurance CO Deciphera Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$12.38 - $20.23 $29,043 - $47,459	2,346 New	2,346 $43,000
Q3 2020 Nov 17, 2020	SELL	$43.8 - $58.16 $1.82 Million - $2.41 Million	-41,448 Reduced 94.64%	2,346 $120,000
Q3 2020 Nov 13, 2020	BUY	$43.8 - $58.16 $1.82 Million - $2.41 Million	41,448 Added 1766.75%	43,794 $2.25 Million
Q4 2019 Feb 11, 2020	BUY	$31.7 - $69.93 $74,368 - $164,055	2,346 New	2,346 $146,000
Q3 2019 Oct 25, 2019	SELL	$19.95 - $38.85 $49,396 - $96,192	-2,476 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$19.08 - $36.14 $47,242 - $89,482	2,476 New	2,476 $50,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.